Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation

Journal of Leukocyte Biology

Volumn 79, Issue 4, 2006, Pages 860-866

  Kramer, Matthijs ^a   Netea, Mihai G ^b   De Jong, Dirk J ^b   Kullberg, Bart Jan ^b   Adema, Gosse J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Human; Toll like receptor

Indexed keywords

B7 ANTIGEN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD86 ANTIGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; MURAMYL DIPEPTIDE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CARD15 PROTEIN, HUMAN; LIGAND; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; SIGNAL PEPTIDE;

ARTICLE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CROHN DISEASE; DENDRITIC CELL; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; ADULT; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; MALE; MIDDLE AGED; MUTATION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADULT; CROHN DISEASE; CYTOKINES; DENDRITIC CELLS; FEMALE; HUMANS; INTERLEUKIN-10; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; TOLL-LIKE RECEPTORS;

EID: 33745556685     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0805484     Document Type: Article

References (33)

1. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., Cho, J. H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
2. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., Thomas, G. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
3. Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., Sansonetti, P. J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872.
4. Traub, S., Kubasch, N., Morath, S., Kresse, M., Hartung, T., Schmidt, R. R., Hermann, C. (2004) Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J. Biol. Chem. 279, 8694-8700.
5. Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S., Takada, H. (2005) Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7, 53-61.
6. Watanabe, T., Kitani, A., Murray, P. J., Strober, W. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5, 800-808.
7. Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., Karin, M. (2005) Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307, 734-738.
8. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., Flavell, R. A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
9. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252.
10. Rigby, R. J., Knight, S. C., Kamm, M. A., Stagg, A. J. (2005) Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin. Exp. Immunol. 139, 245-256.
11. Stagg, A. J., Hart, A. L., Knight, S. C., Kamm, M. A. (2003) The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52, 1522-1529.
12. Stagg, A. J., Hart, A. L., Knight, S. C., Kamm, M. A. (2004) Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. Best Pract. Res. Clin. Gastroenterol. 18, 255-270.
13. Radford-Smith, G., Jewell, D. P. (1996) Cytokines and inflammatory bowel disease. Baillieres Clin. Gastroenterol. 10, 151-164.
14. MacDonald, T. T., Monteleone, G., Pender, S. L. (2000) Recent developments in the immunology of inflammatory bowel disease. Scand. J. Immunol. 51, 2-9.
15. Pallone, F., Monteleone, G. (1996) Regulatory cytokines in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10 (Suppl. 2), 75-79.
16. Kucharzik, T., Stoll, R., Lugering, N., Domschke, W. (1995) Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 100, 452-456.
17. Netea, M. G., Kullberg, B. J., de Jong, D. J., Franke, B., Sprong, T., Naber, T. H., Drenth, J. P., Van der Meer, J. W. (2004) NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur. J. Immunol. 34, 2052-2059.
18. Belaiche, J., Louis, E. (2000) [Treatment of Crohn disease in adults with tumor necrosis factor-α (TNF-α) antibodies]. Rev. Med. Liege 55, 827-832.
19. Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., Quezado, M., Neurath, M. F., Salfeld, J., Veldman, G. M., Schwertschlag, U., Strober, W., Yang, Z. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351, 2069-2079.
20. Stallmach, A., Marth, T., Weiss, B., Wittig, B. M., Hombach, A., Schmidt, C., Neurath, M., Zeitz, M., Zeuzem, S., Abken, H. (2004) An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo. Gut 53, 339-345.
21. Netea, M. G., Ferwerda, G., de Jong, D. J., Jansen, T., Jacobs, L., Kramer, M., Naber, T. H., Drenth, J. P., Girardin, S. E., Jan Kullberg, B., Adema, G. J., Van der Meer, J W. (2005) Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 174, 6518-6523.
22. van Heel, D. A., Ghosh, S., Butler, M., Hunt, K. A., Lundberg, A. M., Ahmad, T., McGovern, D. P., Onnie, C., Negoro, K., Goldthorpe, S., Foxwell, B. M., Mathew, C. G., Forbes, A., Jewell, D. P., Playford, R. J. (2005) Muramyl dipeptide and Toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365, 1794-1796.
23. Bilsborough, J., Viney, J. L. (2004) Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease. Gastroenterology 127, 300-309.
24. Uchijima, M., Nagata, T., Aoshi, T., Koide, Y. (2005) IFN-γ overcomes low responsiveness of myeloid dendritic cells to CpG DNA. Immunol. Cell Biol. 83, 92-95.
25. Huang, H., Jiang, J. X., Zhu, P. F., Wang, Z. G., Zhang, D. J., Yang, C. (2005) [The effects of TNF α and IFN γ on the expression of pattern recognition receptors on the surface of mouse alveolar macrophages]. Zhonghua Wai Ke Za Zhi 43, 740-744.
26. Rosenstiel, P., Fantini, M., Brautigam, K., Kuhbacher, T., Waetzig, G. H., Seegert, D., Schreiber, S. (2003) TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124, 1001-1009.
27. Miceli-Richard, C., Lesage, S., Rybojad, M., Prieur, A. M., Manouvrier-Hanu, S., Hafner, R., Chamaillard, M., Zouali, H., Thomas, G., Hugot, J. P. (2001) CARD15 mutations in Blau syndrome. Nat. Genet. 29, 19-20.
28. Corinti, S., Albanesi, C., la Sala, A., Pastore, S., Girolomoni, G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166, 4312-4318.
29. Duchmann, R., Schmitt, E., Knolle, P., Meyer zum Buschenfelde, K. H., Neurath, M. (1996) Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26, 934-938.
30. Lindsay, J. O., Ciesielski, C. J., Scheinin, T., Brennan, F. M., Hodgson, H. J. (2003) Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis. Gut 52, 981-987.
31. Liu, H., Hu, B., Xu, D., Liew, F. Y. (2003) CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171, 5012-5017.
32. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., Boirivant, M. (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174, 3237-3246.
33. Allez, M., Mayer, L. (2004) Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. 10, 666-676.